Action Evome Medical Technologies - EVMT

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,095

Prix Achat

0,095

Prix Vente

0,105

Volume échangé

2 000

0,095 Fourchette du Jour 0,095

0,00 Plage de 52 semaines 0,00

Cap du marché

5,414M

Clôture Veille

0,10

Ouverture

0,095

Dernière Transaction

500

0.095

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

Actions en circulation

56 991 000

Rendement du Dividende

Ratio Cours sur Bénéfices

-0,80

Bénéfice par action (BPA)

-0,27

Chiffre d'affairess

62,63M

Bénéfice net

-15,6M

Secteur

Med, Dental, Hosp Eq-whsl

Industrie

Unit Inv Tr, Closed-end Mgmt

Site Web

www.salonaglobal.com

Siège social

East Yorkshire, Gbr

Fondé

2015

Evome Medical Technologies Inc est coté dans le secteur Med, Dental, Hosp Eq-whsl de la TSX Venture Exchange avec le ticker EVMT. Le dernier cours de clôture d'Evome Medical Technologies était de $0,10. Au cours de la dernière année, les actions de Evome Medical Technologies ont été négociées dans une fourchette de prix de $ 0,00 à $ 0,00.

Evome Medical Technologies compte actuellement 56 991 000 actions en circulation. La capitalisation boursière d'Evome Medical Technologies est de $5,70 million. Evome Medical Technologies a un ratio cours/bénéfice (ratio PE) de -0.80.

CLARIFICATION: Evome Medical Technologies Announces Significant Debt Restructuring

SHIRLEY, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) issued a press release on Monday...

Evome Medical Technologies Announces Significant Debt Reduction and Restructuring

SHIRLEY, N.Y., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) has announced a significant...

Evome Medical Technologies Grants Restricted Stock Units to New Chief Operating Officer

SHIRLEY, N.Y., Jan. 20, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) is pleased to announce that the...

Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt

SHIRLEY, N.Y., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Shirley, New York, November 25, 2024 – Evome Medical Technologies Inc. (the “Company”) (TSXV:...

Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders

SHIRLEY, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today announced ‎the...

Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan

Posts updated corporate presentation to website Reminder: Conference call to be held on August 19th to discuss Q2 2024 financial results...

Evome Medical Technologies Reports Second Quarter 2024 Financial Results

Stabilizes business with a return to positive Adjusted EBITDAPromotes Gordon Bean to Chief Financial OfficerAnnounces August 19th conference call...

Evome Medical Technologies Retains irlabs for Investor Relations Services

NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) is pleased to announce it...

Evome Medical Technologies Announces Securities Issuances

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) announces it has received...

Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today provided details on...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

EVMT - Frequently Asked Questions (FAQ)

What is the current Evome Medical Technologies share price?

The current share price of Evome Medical Technologies is $ 0,095

How many Evome Medical Technologies shares are in issue?

Evome Medical Technologies has 56 991 000 shares in issue

What is the market cap of Evome Medical Technologies?

The market capitalisation of Evome Medical Technologies is CAD 5,7M

What is the 1 year trading range for Evome Medical Technologies share price?

Evome Medical Technologies has traded in the range of $ 0,00 to $ 0,00 during the past year

What is the PE ratio of Evome Medical Technologies?

The price to earnings ratio of Evome Medical Technologies is -0,8

What is the cash to sales ratio of Evome Medical Technologies?

The cash to sales ratio of Evome Medical Technologies is 0,2

What is the reporting currency for Evome Medical Technologies?

Evome Medical Technologies reports financial results in CAD

What is the latest annual turnover for Evome Medical Technologies?

The latest annual turnover of Evome Medical Technologies is CAD 62,63M

What is the latest annual profit for Evome Medical Technologies?

The latest annual profit of Evome Medical Technologies is CAD -15,6M

What is the registered address of Evome Medical Technologies?

The registered address for Evome Medical Technologies is SUITE 200E - 1515A BAYVIEW AVENUE, EAST YORKSHIRE, M4G 3B5

What is the Evome Medical Technologies website address?

The website address for Evome Medical Technologies is www.salonaglobal.com

Which industry sector does Evome Medical Technologies operate in?

Evome Medical Technologies operates in the UNIT INV TR, CLOSED-END MGMT sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ADEAdex Mining Inc	$ 0,015 (200,00%)	8,2k
PLAPlata Latina Minerals Corporation	$ 0,025 (150,00%)	862k
RECRecord Resources Inc	$ 0,04 (100,00%)	1,45M
NNXNickel North Exploration Corp	$ 0,02 (100,00%)	7k
ENEVEnerev5 Metals Inc	$ 0,01 (100,00%)	15,95k
SOP.HSoperior Fertilizer Corp	$ 0,005 (-50,00%)	903k
TVC.HThree Valley Copper Corp	$ 0,005 (-50,00%)	35k
PORPortofino Resources Inc	$ 0,005 (-50,00%)	13,14k
FONC.PFlorence One Capital Inc	$ 0,02 (-42,86%)	10k
TZR.HTerrace Energy Corp	$ 0,065 (-38,10%)	699
TBXTurmalina Metals Corp	$ 0,15 (11,11%)	3,27M
MAEMaritime Resources Corp	$ 0,08 (6,67%)	2,76M
NEVNevada Sunrise Metals Corporation	$ 0,015 (0,00%)	2,64M
SPZSuperBuzz Inc	$ 0,04 (14,29%)	2,53M
VXTRVoxtur Analytics Corp	$ 0,04 (-20,00%)	2,22M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Evome Medical Technologies Inc (EVMT)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Evome Medical Technologies Inc

EVMT Dernières nouvelles

CLARIFICATION: Evome Medical Technologies Announces Significant Debt Restructuring

Evome Medical Technologies Announces Significant Debt Reduction and Restructuring

Evome Medical Technologies Grants Restricted Stock Units to New Chief Operating Officer

Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt

Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders

Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan

Evome Medical Technologies Reports Second Quarter 2024 Financial Results

Evome Medical Technologies Retains irlabs for Investor Relations Services

Evome Medical Technologies Announces Securities Issuances

Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2

CLARIFICATION: Evome Medical Technologies Announces Significant Debt Restructuring

Evome Medical Technologies Announces Significant Debt Reduction and Restructuring

Evome Medical Technologies Grants Restricted Stock Units to New Chief Operating Officer

Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt

Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders

Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan

Evome Medical Technologies Reports Second Quarter 2024 Financial Results

Evome Medical Technologies Retains irlabs for Investor Relations Services

EVMT - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Evome Medical Technologies Inc (EVMT) Cours

Evome Medical Technologies Inc (EVMT)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Evome Medical Technologies Inc

EVMT Dernières nouvelles

CLARIFICATION: Evome Medical Technologies Announces Significant Debt Restructuring

Evome Medical Technologies Announces Significant Debt Reduction and Restructuring

Evome Medical Technologies Grants Restricted Stock Units to New Chief Operating Officer

Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt

Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders

Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan

Evome Medical Technologies Reports Second Quarter 2024 Financial Results

Evome Medical Technologies Retains irlabs for Investor Relations Services

Evome Medical Technologies Announces Securities Issuances

Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2

CLARIFICATION: Evome Medical Technologies Announces Significant Debt Restructuring

Evome Medical Technologies Announces Significant Debt Reduction and Restructuring

Evome Medical Technologies Grants Restricted Stock Units to New Chief Operating Officer

Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt

Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders

Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan

Evome Medical Technologies Reports Second Quarter 2024 Financial Results

Evome Medical Technologies Retains irlabs for Investor Relations Services

EVMT - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS